@Demeetra

Demeetra has been a member of Linktree for 6 years and joined in May 2020. The social media accounts linked to from Demeetra are: • Facebook • Instagram • LinkedIn • X Besides social media accounts, Demeetra has populated their site with: • Visit Demeetra Website • Schedule A Call • Shop Demeetra Gene Editing Technology • CRISPR Medicine News Interview with Demeetra AgBio CEO | Demeetra AgBio • Protein Engineered Cas-CLOVER Yields 99% Gene Editing Efficiency and Ultra-Low Toxicity • Seamlessly Upgrade Your CRISPR Toolbox From Cas9 to Cas-CLOVER™ • Seedless Fruit Production With Gene Editing • Cas-CLOVER & piggyBac: Simple Yeast Strain Development • Glycoengineering strategies for improved biologics manufacturing • 9th Annual Plant Genomics & Gene Editing Congress • Cas-CLOVER’s Key Advantages In Animal Model Gene Editing • Designing gRNA User Guide • The Greatest Gene Editing Technology on the Planet? • The Significance Of Genetically Modifying Glutamate In Plants • piggyBac: A Simple, Versatile & Efficient Tool For Yeast Strain Development • Gene Editing in Plants Is Stable, Efficient, and Reliable With Cas-CLOVER, The Clean Alternative to CRISPR/Cas9 • PiggyBac: A Simple and Easy to Use Tool to Accelerate Development of Cultured Meats and Cell Lines for the Production of Food Proteins • ROI Of Using Cas-CLOVER vs. CRISPR/Cas9 In Cell Line Development For Commercial Therapeutic Bioprocessing • Increasing Plant Gene Editing Efficiency with Cas-CLOVER • Cas-CLOVER: High-Performing Yeast Strains Datasheet • Larger Deletions, Easier Screening With Demeetra’s Cas-CLOVER Technology • piggyBac Transposase In Non-Conventional Yeasts: Metabolites And Small Molecules • CAS-CLOVER: The Clean Alternative to CRISPR/Cas9 For Bioprocessing • Use piggyBac for Cell Line Engineering • Cas-CLOVER Enables Unlimited Cell Bioprocessing Platform Improvement Opportunities • Cas-CLOVER's Stable Editing in Tobacco • Cas-CLOVER in CHO Cells • Demeetra with Sanofi at BioProcess International 2021 • Cas-CLOVER And Its Advantages Over Nobel Award-Winning CRISPR/Cas9